Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathy-Reference-Cited by-同舟云学术

Serelaxin attenuates renal inflammation and fibrosis in a mouse model of dilated cardiomyopathy

Published:2018-11-05 Issue:12 Volume:103 Page:1593-1602
ISSN:0958-0670
Container-title:Experimental Physiology
language:en
Short-container-title:Exp Physiol

Author:

Giam Beverly¹²^ORCID,Chu Po-Yin¹,Kuruppu Sanjaya³,Smith A. Ian³,Horlock Duncan¹,Murali Aishwarya¹,Kiriazis Helen¹,Du Xiao-Jun¹,Kaye David M.¹⁴,Rajapakse Niwanthi W.¹⁵

Affiliation:

1. Baker Heart and Diabetes Institute; Melbourne Victoria Australia

2. Central Clinical School; Monash University; Melbourne Victoria Australia

3. Biomedicine Discovery Institute; Department of Biochemistry & Molecular Biology; Monash University; Melbourne Victoria Australia

4. Department of Medicine; Monash University; Melbourne Victoria Australia

5. School of Biomedical Sciences; University of Queensland; Brisbane Queensland Australia

Funder

Novartis

National Health and Medical Research Council

Publisher

Wiley

Subject

Physiology,Physiology (medical),Nutrition and Dietetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1113/EP087189/fullpdf

Reference33 articles.

1. Comparison between the enzymatic vitros assay for creatinine determination and three other methods adapted on the Olympus analyzer;Badiou;Journal of Clinical Laboratory Analysis,2003

2. CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess;Chu;Circulation: Heart Failure,2011

3. Inflammatory activation: Cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome;Colombo;Heart Failure Reviews,2012

4. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: Workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI);Cruz;Contributions to Nephrology,2013

5. Relaxin improves TNF-α-induced endothelial dysfunction: The role of glucocorticoid receptor and phosphatidylinositol 3-kinase signalling;Dschietzig;Cardiovascular Research,2012

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac and Renal Fibrosis, the Silent Killer in the Cardiovascular Continuum: An Up-to-Date;Journal of Cardiovascular Development and Disease;2024-02-16

2. Relaxin in fibrotic ligament diseases: Its regulatory role and mechanism;Frontiers in Cell and Developmental Biology;2023-04-11

3. Relaxin contributes to the elevation of monocytic myeloid-derived suppressor cells in peripheral blood of pregnant canines;Journal of Reproductive Immunology;2023-02

4. Relaxin as an anti-fibrotic treatment: Perspectives, challenges and future directions;Biochemical Pharmacology;2022-03

5. Relaxin in hepatic fibrosis: What is known and where to head?;Biochimie;2021-08